The first anti-COVID pill Molnupiravir was issued an Emergency Use Authorization (EUA) by the FDA. EUA for Pfizer’s COVID-19 vaccine was amended and approved for individuals 5-11 years old.
The first anti-COVID pill Molnupiravir was issued an Emergency Use Authorization (EUA) by the FDA. EUA for Pfizer’s COVID-19 vaccine was amended and approved for individuals 5-11 years old.